Absci Corp
ABSIServices-Commercial Physical & Biological Research · SIC 8731 · CIK 0001672688
Revenue FY2025
$3.0M
Net Income
$(115.0M)
EPS (Basic)
$-0.84
Net Margin
-4113.7%
ROE
-60.8%
Total Equity
$189.0M
Shares Out
172M
Absci Corp — Services-Commercial Physical & Biological Research. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2020–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 5 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
ARK Investment Management
ARK Investment Management
$149.8M
0.9%
(5.8%)
Platinum Investment Management
Platinum Investment Management
$2.8M
0.7%
—
Adage Capital Management
Adage Capital Management
$66.1M
0.1%
NEW
Baker Bros. Advisors
Baker Bros. Advisors
$24.7M
0.1%
—
Royce & Associates
Royce & Associates
$5.2M
0.0%
(39.4%)
Insider Transactions
Reading stored insider transactions…